Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Jak3 activation in human lymphocyte precursor cells

N Sharfe1, H K Dadi, J J O'Shea

  • 1Department of Pediatrics, University of Toronto and the Hospital for Sick Children, Canada.

Clinical and Experimental Immunology
|June 1, 1997
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Cholesterol 25-hydroxylase is a metabolic switch to constrain T cell-mediated inflammation in the skin.

Science immunology·2021
Same author

Genetic analysis of inherited bone marrow failure syndromes from one prospective, comprehensive and population-based cohort and identification of novel mutations.

Journal of medical genetics·2011
Same author

Efficacy and safety of home-based subcutaneous immunoglobulin replacement therapy in paediatric patients with primary immunodeficiencies.

Clinical and experimental immunology·2011
Same author

Combined immunodeficiency, facial dysmorphism, optic nerve atrophy, skeletal anomalies and developmental delay: a new syndrome.

Clinical genetics·2009
Same author

Altered balance between Th17 and Th1 cells at mucosal sites predicts AIDS progression in simian immunodeficiency virus-infected macaques.

Mucosal immunology·2008
Same author

Key molecules involved in receptor-mediated lymphocyte activation.

Current protocols in immunology·2008

Janus kinase 3 (Jak3) is expressed early in T cell development, not just in mature cells. This finding is crucial for understanding severe combined immunodeficiency (SCID) caused by Jak3 mutations.

Area of Science:

  • Immunology
  • Molecular Biology
  • Cell Biology

Background:

  • Janus kinase 3 (Jak3) tyrosine kinase expression was previously believed to be limited to mature, activated T lymphocytes.
  • Mutations in Jak3 are linked to severe combined immunodeficiency (SCID), a condition marked by a lack of peripheral T lymphocytes.

Purpose of the Study:

  • To investigate the expression pattern of Jak3 throughout human T cell differentiation.
  • To determine if Jak3 plays a role in early T cell development and B cell development.

Main Methods:

  • Detailed examination of Jak3 expression during human T cell differentiation.
  • Analysis of Jak3 activation via the Interleukin-7 (IL-7) receptor in thymocytes.
  • Investigation of Jak3 expression in human pre-B cells.

Related Experiment Videos

Main Results:

  • Jak3 is expressed throughout human T cell development, with high levels in thymocytes, including early double-negative (CD4- CD8-) cells.
  • IL-7 receptor activation of Jak3 in thymocytes suggests a role in T cell receptor (TCR) gene rearrangement and proliferation.
  • Jak3 is also expressed in human pre-B cells and can be activated by IL-7.

Conclusions:

  • Jak3 expression is not restricted to mature T cells but is present throughout T cell differentiation, starting from early thymocyte stages.
  • The role of Jak3 in early T cell development, particularly its activation by IL-7, is critical for normal T cell formation.
  • Jak3's presence and activation in pre-B cells indicate its importance in both T and B lymphocyte development, offering insights into SCID pathogenesis.